http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107153117-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-95 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57446 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56966 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
filingDate | 2016-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107153117-B |
titleOfInvention | It is a kind of for judge target mab treatment tumor efficiency predictive molecule |
abstract | The invention discloses a kind of for judging the predictive molecule of targeting mab treatment tumor efficiency.Whether the present invention provides the substances of detection PRSS1 expression quantity detects tumour cell to be measured to the application in targeting EGFR monoclonal antibody drug resistance product in preparation;Or whether the substance of detection PRSS1 expression quantity detects tumor patient to be measured to the application in targeting EGFR monoclonal antibody drug resistance product in preparation;The experiment proves that, PRSS1 can be used as a kind of examination of curative effect molecule of adjuvant clinical medication, i.e. clinically by the expression of monitoring patient's body PRSS1, curative effect of the predictable patient to monoclonal antibody, and effective therapeutic scheme is replaced in time, to improve the curative effect of patient, improve the quality of life of patient. |
priorityDate | 2016-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 259.